Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05694 | 33152949 | Biomed Pharmacother | Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice. | 2020 | Details |
| A05695 | 33152943 | Biomed Pharmacother | The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. | 2020 | Details |
| A05696 | 33152542 | Clin Gastroenterol Hepatol | A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05697 | 33152322 | Cell Metab | TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation. | 2020 | Details |
| A05698 | 33151407 | J Gastroenterol | The gut mycobiome: a novel player in chronic liver diseases. | 2020 | Details |
| A05699 | 33150534 | Eat Weight Disord | Liver disease in obesity and underweight: the two sides of the coin. A narrative review. | 2020 | Details |
| A05700 | 33150145 | J Hepatocell Carcinoma | Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma. | 2020 | Details |
| A05701 | 33149882 | Ther Adv Endocrinol Metab | Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications. | 2020 | Details |
| A05702 | 33149855 | Iran J Basic Med Sci | Effect of soy consumption on liver enzymes, lipid profile, anthropometry indices, and oxidative stress in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials. | 2020 | Details |
| A05703 | 33149804 | Oxid Med Cell Longev | Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A05705 | 33148902 | J Med Invest | Long-term empagliflozin therapy improves levels of hepatic fibrosis marker in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus. | 2020 | Details |
| A05706 | 33148171 | BMC Gastroenterol | Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease. | 2020 | Details |
| A05707 | 33147705 | Nutrients | Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial. | 2020 | Details |
| A05709 | 33146212 | Food Funct | The influence of dietary conditions in the effects of resveratrol on hepatic steatosis. | 2020 | Details |
| A05710 | 33145434 | Clin Exp Hepatol | Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A05711 | 33145428 | Clin Exp Hepatol | Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease. | 2020 | Details |
| A05712 | 33145423 | Clin Exp Hepatol | Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis - epidemiology, risk factors, clinical implications and treatment. | 2020 | Details |
| A05713 | 33144913 | Oxid Med Cell Longev | Amelioration by Idesia polycarpa Maxim. var. vestita Diels. of Oleic Acid-Induced Nonalcoholic Fatty Liver in HepG2 Cells through Antioxidant and Modulation of Lipid Metabolism. | 2020 | Details |
| A05714 | 33144268 | Ann Anat | Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice? | 2020 | Details |
| A05715 | 33144092 | Peptides | Chemerin/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway. | 2020 | Details |
| A05716 | 33144054 | Dig Liver Dis | Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population. | 2020 | Details |
| A05717 | 33143903 | Pathology | Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies. | 2020 | Details |
| A05718 | 33143886 | Chemosphere | Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol diet. | 2020 | Details |
| A05719 | 33143650 | BMC Gastroenterol | HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling. | 2020 | Details |
| A05720 | 33143628 | Curr Diabetes Rev | Hepatic Mediators of Lipid Metabolism and Ketogenesis: Focus on Fatty Liver and Diabetes. | 2021 | Details |
| A05721 | 33143364 | Int J Mol Sci | DNA Methylation in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05722 | 33143061 | Nutrients | Cafeteria Diet and High-Fructose Rodent Models of NAFLD Differ in the Metabolism of Important PUFA and Palmitoleic Acid without Additional Influence of Sex. | 2020 | Details |
| A05723 | 33143043 | Biomolecules | Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update. | 2020 | Details |
| A05724 | 33142854 | Life (Basel) | Investigation of Genetic Modifiers of Copper Toxicosis in Labrador Retrievers. | 2020 | Details |
| A05725 | 33142714 | J Clin Med | Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis. | 2020 | Details |
| A05726 | 33142400 | Zhonghua Yi Xue Za Zhi | [The evaluation value of transient elastography for liver characteristics in obese children]. | 2020 | Details |
| A05727 | 33142354 | Clin Transl Sci | Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05728 | 33142346 | Planta Med | Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05729 | 33142287 | Dig Dis | Natural History of Cirrhosis: Changing Trends in Etiology Over the Years. | 2020 | Details |
| A05730 | 33141341 | Drug Saf | Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05732 | 33140878 | J Gastroenterol Hepatol | Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China. | 2021 | Details |
| A05733 | 33140733 | Biomed Khim | [Relationship between metabolic and immunological disorders in experimental acute tetrachlomethane, ischemic and alcoholic liver disease]. | 2020 | Details |
| A05734 | 33140427 | Hepatology | Associations Between Intake of Sugar-Containing Beverages in Infancy With Liver Fat Accumulation at School Age. | 2021 | Details |
| A05735 | 33139661 | Int J Mol Sci | Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome. | 2020 | Details |
| A05736 | 33139607 | Nutrients | Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease? | 2020 | Details |
| A05737 | 33138044 | Cancers (Basel) | Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role. | 2020 | Details |
| A05738 | 33137488 | Mol Metab | The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice. | 2020 | Details |
| A05739 | 33137486 | Clin Gastroenterol Hepatol | Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease. | 2020 | Details |
| A05740 | 33136722 | Eur J Gastroenterol Hepatol | Risk factors and characteristics associated with nonalcoholic fatty liver disease in patients with ischemic colitis. | 2021 | Details |
| A05741 | 33136250 | J Med Ultrason (2001) | Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
| A05742 | 33135718 | Food Funct | Integrative transcriptomics and metabolomics explore the mechanism of kaempferol on improving nonalcoholic steatohepatitis. | 2020 | Details |
| A05743 | 33135331 | J Diabetes Investig | Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease. | 2020 | Details |
| A05744 | 33134908 | JHEP Rep | Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor. | 2020 | Details |
| A05745 | 33134907 | JHEP Rep | Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg. | 2020 | Details |
| A05746 | 33134809 | Rheumatol Adv Pract | Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study. | 2020 | Details |
| A05747 | 33134485 | Transplant Direct | Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma. | 2020 | Details |
| A05748 | 33133572 | Food Sci Nutr | Alleviative effect of Ruellia tuberosa L. on NAFLD and hepatic lipid accumulation via modulating hepatic de novo lipogenesis in high-fat diet plus streptozotocin-induced diabetic rats. | 2020 | Details |
| A05749 | 33133304 | Dis Markers | Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. | 2020 | Details |
| A05750 | 33132768 | ScientificWorldJournal | Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin. | 2020 | Details |
| A05751 | 33132645 | World J Gastroenterol | Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A05752 | 33132636 | World J Gastroenterol | Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis? | 2020 | Details |
| A05753 | 33132631 | World J Gastroenterol | Role of betaine in liver disease-worth revisiting or has the die been cast? | 2020 | Details |
| A05754 | 33132423 | Nagoya J Med Sci | Chronic inflammation as a molecular basis of nonalcoholic steatohepatitis: role of macrophages and fibroblasts in the liver. | 2020 | Details |
| A05755 | 33132309 | Biol Pharm Bull | Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling. | 2020 | Details |
| A05756 | 33131747 | Life Sci | Metabolomic-proteomic combination analysis reveals the targets and molecular pathways associated with hydrogen sulfide alleviating NAFLD. | 2020 | Details |
| A05757 | 33131411 | Gut Microbes | Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum. | 2020 | Details |
| A05758 | 33131199 | J Diabetes Investig | Favorable effect of sodium-glucose cotransporter 2 inhibitor, dapagliflozin, on non-alcoholic fatty liver disease compared with pioglitazone. | 2020 | Details |
| A05759 | 33131062 | Hepatology | Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis. | 2021 | Details |
| A05760 | 33130334 | Ann Hepatol | Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience. | 2020 | Details |
| A05762 | 33129272 | BMC Gastroenterol | Retrospective analysis of a dedicated care pathway for nonalcoholic fatty liver disease in an integrated US healthcare system demonstrates support of weight management and improved ALT. | 2020 | Details |
| A05763 | 33128454 | Eur J Clin Invest | A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. | 2020 | Details |
| A05764 | 33127939 | Sci Rep | Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid. | 2020 | Details |
| A05765 | 33127832 | Gut | MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. | 2020 | Details |
| A05766 | 33127749 | J Pharmacol Exp Ther | Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III. | 2020 | Details |
| A05767 | 33126575 | Nutrients | Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. | 2020 | Details |
| A05768 | 33126512 | Int J Environ Res Public Health | Prenatal Exposure to Gutkha, a Globally Relevant Smokeless Tobacco Product, Induces Hepatic Changes in Adult Mice. | 2020 | Details |
| A05769 | 33126411 | Cells | The Role of PPARs in Disease. | 2020 | Details |
| A05770 | 33126313 | Medicine (Baltimore) | The efficacy of Qigong exercises for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2020 | Details |
| A05771 | 33126224 | Aging (Albany NY) | GDF11 induces mild hepatic fibrosis independent of metabolic health. | 2020 | Details |
| A05772 | 33125745 | Hepatology | Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. | 2021 | Details |
| A05773 | 33125573 | Mikrochim Acta | Immobilization of cell membrane onto a glucose-Zn-based porous coordination polymer and its application to rapid screening of potentially active compounds from Vaccinium corymbosum L. leaves. | 2020 | Details |
| A05775 | 33125080 | J Clin Endocrinol Metab | Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05776 | 33123227 | Exp Ther Med | Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD. | 2020 | Details |
| A05777 | 33122711 | Sci Rep | Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy. | 2020 | Details |
| A05778 | 33122322 | BMJ Open | Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey. | 2020 | Details |
| A05779 | 33122078 | Gene | TCTP participates in hepatic metabolism by regulating gene expression involved in insulin resistance. | 2020 | Details |
| A05780 | 33121337 | Cell Cycle | Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway. | 2020 | Details |
| A05781 | 33119943 | Br J Pharmacol | Intestinal absorption and hepatic elimination of drugs in high-fat high-cholesterol diet-induced non-alcoholic steatohepatitis rats: exemplified by simvastatin. | 2020 | Details |
| A05782 | 33119748 | J Clin Endocrinol Metab | Associations of Hair Cortisol Concentrations with General and Organ Fat Measures in Childhood. | 2021 | Details |
| A05783 | 33117844 | Front Nutr | Complex Dietary Topologies in Non-alcoholic Fatty Liver Disease: A Network Science Analysis. | 2020 | Details |
| A05784 | 33117662 | Psoriasis (Auckl) | Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter. | 2020 | Details |
| A05785 | 33117448 | Eur Endocrinol | The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women - A Cross-sectional Study from Southern India. | 2020 | Details |
| A05786 | 33117316 | Front Microbiol | Microbial Metabolites: Critical Regulators in NAFLD. | 2020 | Details |
| A05787 | 33117273 | Front Endocrinol (Lausanne) | Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice. | 2020 | Details |
| A05788 | 33116732 | Diabetes Metab Syndr Obes | Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH. | 2020 | Details |
| A05789 | 33116724 | Diabetes Metab Syndr Obes | Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome. | 2020 | Details |
| A05790 | 33116709 | Diabetes Metab Syndr Obes | Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05791 | 33116702 | Diabetes Metab Syndr Obes | Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05792 | 33115780 | Cancer Prev Res (Phila) | Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer. | 2020 | Details |
| A05793 | 33115209 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming. | 2020 | Details |
| A05794 | 33114589 | Molecules | Modulation of Lipid Metabolism by Trans-Anethole in Hepatocytes. | 2020 | Details |
| A05795 | 33114564 | Nutrients | Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation. | 2020 | Details |
| A05796 | 33114543 | J Clin Med | Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity. | 2020 | Details |
| A05797 | 33114323 | J Clin Med | Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. | 2020 | Details |
| A05798 | 33114299 | Antioxidants (Basel) | Comparative Effects of Pterostilbene and Its Parent Compound Resveratrol on Oxidative Stress and Inflammation in Steatohepatitis Induced by High-Fat High-Fructose Feeding. | 2020 | Details |